Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma, Extranodal NK-T-Cell 1 Liver Neoplasms 1

Interventions

durvalumab 7 Bevacizumab 6 tremelimumab 3 Nivolumab 3 lenvatinib 2 fludarabine 2 Cyclophosphamide 2 zimberelimab 1 toripalimab 1 ropidoxuridine 1 relatlimab 1 pembrolizumab 1 fludarabine phosphate 1 atezolizumab 1 X-Rays 1 Technetium Tc 99m Aggregated Albumin 1 Standard of Care 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radionuclide Imaging 1 Platinum 1 Photons 1 Paclitaxel 1 Observation 1 Long-Term Potentiation 1 Lidocaine 1 Immunotherapy 1 Immunoglobulin G 1 IMC-001 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Liver Neoplasms × IMC-001 × Clear all

NCT04196465 2026-05-22

NeoChance

Asan Medical Center

Phase 2 Active not recruiting

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡